Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03MDW
|
|||
| Former ID |
DNCL003433
|
|||
| Drug Name |
DS-7309
|
|||
| Indication | Diabetic complication [ICD-11: 5A2Y; ICD-9: 253.5, 588.1] | Phase 1 | [1] | |
| Company |
Daiichi Sankyo
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H19NO
|
|||
| Canonical SMILES |
CC1CN(CC(C1=O)C)CC2=CC=CC=C2
|
|||
| InChI |
1S/C14H19NO/c1-11-8-15(9-12(2)14(11)16)10-13-6-4-3-5-7-13/h3-7,11-12H,8-10H2,1-2H3
|
|||
| InChIKey |
KUUYMZATYJQLLZ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 836-21-5
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01956305) Randomized, Placebo-controlled, 2 Period, Single-blind, Sequential, Multiple Ascending Dose Study. U.S. National Institutes of Health. | |||
| REF 2 | Glucokinase alternative. SciBX 6(45); doi:10.1038/scibx.2013.1279. Nov. 21 2013 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.